Personalized Medical Care & Dedicated International Patient Concierge
Medical Guide
Menopause & Osteoporosis: How They're Connected and Treated
Learn how menopause and osteoporosis are connected, explore risk factors, prevention strategies, and treatment options to protect your bone health.
Schedule a ConsultationUnderstanding the Link Between Menopause and Osteoporosis

For many women, menopause marks a significant turning point in long-term health — not just in terms of hormonal shifts, but in bone health as well. What is less widely understood is that the decline in estrogen that defines menopause is one of the primary drivers of osteoporosis, a condition that causes bones to become porous, brittle, and vulnerable to fracture.
Estrogen plays a protective role in bone metabolism. It helps regulate the balance between osteoblasts, the cells that build bone, and osteoclasts, the cells that break it down. When estrogen levels fall during perimenopause and menopause, this balance is disrupted. Bone resorption accelerates while new bone formation cannot keep pace. The result is a measurable and progressive loss of bone mineral density (BMD).
In the first five to seven years following menopause, women can lose as much as 20% of their bone density. This rapid decline significantly raises the risk of fragility fractures — particularly in the spine, hip, and wrist — injuries that can have serious consequences for independence and quality of life in later years.
The Yonsei Miz Women's Clinic, located in Gangnam District, Seoul, South Korea, offers an integrated approach to women's health that addresses this connection directly, providing evidence-based assessment and individualized treatment for women navigating both menopause and osteoporosis.
Who Is at Risk?
Not every woman will develop osteoporosis after menopause, but certain factors increase susceptibility. These include:
- Early menopause (before age 45), whether natural or surgical
- A family history of osteoporosis or hip fractures
- Low body weight or a small frame
- Long-term use of corticosteroids or certain other medications
- Low calcium or vitamin D intake over many years
- Sedentary lifestyle or limited weight-bearing activity
- History of smoking or excessive alcohol use
Women who experience premature ovarian insufficiency or who have undergone oophorectomy (removal of the ovaries) face an especially heightened risk due to extended estrogen deficiency. Asian women also tend to have lower baseline bone density compared to other ethnic groups, making proactive screening particularly important in the Korean clinical context.
Diagnosis and Evaluation at The Yonsei Miz Women's Clinic

Accurate diagnosis is the foundation of effective management. At The Yonsei Miz Women's Clinic, evaluation typically begins with a comprehensive health history and is followed by a DEXA scan (dual-energy X-ray absorptiometry), the gold-standard imaging test for measuring bone mineral density. Results are expressed as a T-score, which compares a patient's bone density to that of a healthy young adult.
- A T-score of −1.0 or above is considered normal
- Between −1.0 and −2.5 indicates osteopenia (low bone density)
- −2.5 or below confirms osteoporosis
In addition to bone density imaging, the clinic may assess hormonal profiles, calcium and vitamin D levels, kidney function, and fracture risk using validated tools such as FRAX, a clinical algorithm that calculates the 10-year probability of a major osteoporotic fracture.
Treatment Options: A Personalised, Multifaceted Approach

Hormone Therapy
For women in early menopause who are experiencing both menopausal symptoms and accelerated bone loss, hormone therapy (HT) remains one of the most effective interventions. By restoring circulating estrogen, HT can significantly slow bone resorption and preserve density — often while simultaneously improving quality of life through relief of hot flashes, sleep disturbances, and mood changes.
The decision to initiate hormone therapy is made carefully and individually. Candidates are evaluated for contraindications, including personal or family history of hormone-sensitive cancers, cardiovascular disease, or thromboembolic conditions. For suitable candidates, the benefits of HT in both symptom relief and fracture prevention can be substantial.
Bone-Targeted Medications
For women who are not candidates for hormone therapy, or whose bone density loss is severe, a range of non-hormonal medications is available:
- Bisphosphonates (such as alendronate and risedronate) are among the most commonly prescribed agents. They work by inhibiting osteoclast activity, slowing the rate of bone breakdown. They are typically taken weekly or monthly and have a well-established safety record.
- Denosumab is an injectable medication given every six months. It targets a specific protein involved in osteoclast activation and is particularly useful for women who cannot tolerate bisphosphonates.
- Selective Estrogen Receptor Modulators (SERMs) such as raloxifene mimic estrogen's protective effect on bone while avoiding stimulation of breast or uterine tissue.
- Anabolic agents such as teriparatide are reserved for women with severe osteoporosis or multiple fractures. These medications actively stimulate new bone formation rather than simply slowing its loss.
Nutritional and Lifestyle Support
Medication is most effective when combined with foundational lifestyle adjustments. Adequate calcium intake — typically 1,200 mg per day for postmenopausal women — and sufficient vitamin D are essential. Weight-bearing exercise such as walking, resistance training, and balance work supports bone maintenance and also reduces fall risk. Smoking cessation and moderation of alcohol intake further protect bone health.
The Role of Dr. Ye-ri Lee and Dr. Jong-sik Jeon
The Yonsei Miz Women's Clinic brings together clinicians with a background in women's health and gynecological care. Dr. Ye-ri Lee and Dr. Jong-sik Jeon approach menopause and bone health within the broader framework of women's long-term wellbeing, recognising that hormonal transitions affect multiple body systems simultaneously.
Consultations at the clinic are designed to be thorough and patient-centred, allowing time for a detailed discussion of symptoms, risk factors, lifestyle context, and treatment preferences. This collaborative process supports informed decision-making rather than a one-size-fits-all protocol.
Recovery, Safety, and Realistic Outcomes
Osteoporosis management is a long-term commitment rather than a short-term intervention. Most treatments require consistent use over months to years to demonstrate measurable improvements in bone density, with follow-up DEXA scans typically scheduled every one to two years.
For the majority of women, treatment does not reverse bone loss already sustained but meaningfully slows further deterioration and, with anabolic agents, can produce genuine gains in bone mass. Fracture risk can be substantially reduced — in some studies, bisphosphonate therapy reduces vertebral fracture risk by up to 50%.
Side effects vary by treatment and are monitored regularly. Hormone therapy carries risks that must be weighed individually. Bisphosphonates are generally well-tolerated, though rare side effects including jaw osteonecrosis and atypical femoral fractures are monitored with long-term use.
Why Seek Care in Gangnam, Seoul?
South Korea has invested substantially in women's health infrastructure, and clinics in Gangnam District reflect that investment in both clinical expertise and diagnostic capability. For international patients, The Yonsei Miz Women's Clinic offers a setting where complex, intersecting conditions like menopause and osteoporosis can be evaluated and managed with continuity.
Women experiencing symptoms of perimenopause, or those who have been postmenopausal for several years without bone density evaluation, are encouraged to seek assessment sooner rather than later. Early intervention remains the most effective way to preserve bone health and reduce fracture risk over the decades ahead.
More Articles
Continue reading our clinical guides.
When Is Gynecologic Surgery the Right Choice?
When is gynecologic surgery the right choice? Learn about common conditions, treatment options, benefits, and when to consult a specialist today.
Learn More
Menopause & Osteoporosis: How They're Connected and Treated
Learn how menopause and osteoporosis are connected, explore risk factors, prevention strategies, and treatment options to protect your bone health.
Learn More
Women's Cancer Screening: Which Tests Matter and When
Learn which women's cancer screening tests matter, when to get screened, and how early detection can improve outcomes. Schedule your screening today.
Learn More